Dexamethasone + tobramycin (eye drops)

Generic name
Dexamethasone + tobramycin (eye drops)
Brand name
ATC Code
S01CA01

Dexamethasone + tobramycin (eye drops)

Dosages
Side effects in children
Warnings & precautions in children
Contra-indications in children

Interactions
PK
Renal impairment
References

Pharmacokinetics in children

No information is present at this moment.

dose recommendation of formulary compared to licensed use (on-label versus off-label)

No information is present at this moment.

Available formulations

No information is present at this moment.

Dosages

Eye infections
  • Ocular
    • Eye salve
      • 0 years up to 18 years
        • Apply a small amount (piece of about 1.5 cm) in the conjunctival sac or sacs, up to 3 or 4
          times daily, or only before bed in addition to the drops used during the day.

        • Duration of treatment:

          Maximum 14 days

      • 0 years up to 18 years
        [2]
        • Apply a small amount (piece of about 1.5 cm) in the conjunctival sac or sacs, up to 3 or 4
          times daily, or only before bed in addition to the drops used during the day.

        • Duration of treatment:

          Maximum 14 days

Renal impaiment in children > 3 months

No information available on dose adjustment in renal impairment.

The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here

Side effects

No information is present at this moment.

The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here

Contra-indications

No information available on specific contra indications in children.

The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here

Warnings & precautions in children

In children and adolescents, the intraocular pressure should be checked regularly. This is especially important in pediatric patients receiving drugs containing dexamethasone, as the risk of steroid-induced ocular hypertension in children under 6 years of age can be higher and appear earlier than in adults.

Interactions

The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here

ANTIINFLAMMATORY AGENTS AND ANTIINFECTIVES IN COMBINATION

This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.

Corticosteroids and antiinfectives in combination
S01CA01
S01CA03

References

  1. Alcon Nederland BV, SmPC Tobradex (RVG 14223) 27-10-2015, www.geneesmiddeleninformatiebank.nl
  2. Alcon Nederland BV, SmPC Tobradex (RVG 14224) 04-11-2014, www.geneesmiddeleninformatiebank.nl

Changes

Therapeutic Drug Monitoring


Overdose